AIMC Topic: Drug Discovery

Clear Filters Showing 1181 to 1190 of 1689 articles

Adverse Drug Reaction Predictions Using Stacking Deep Heterogeneous Information Network Embedding Approach.

Molecules (Basel, Switzerland)
Inferring potential adverse drug reactions is an important and challenging task for the drug discovery and healthcare industry. Many previous studies in computational pharmacology have proposed utilizing multi-source drug information to predict drug ...

A Neural Network QSPR Model for Accurate Prediction of Flash Point of Pure Hydrocarbons.

Molecular informatics
The present study introduces a QSPR model to predict the flash point of pure organic compounds from diverse chemical families. We used the Maximum-Relevance Minimum-Redundancy (MRMR) as an efficient descriptor selection algorithm to select 20 the mos...

Advances with support vector machines for novel drug discovery.

Expert opinion on drug discovery
Novel drug discovery remains an enormous challenge, with various computer-aided drug design (CADD) approaches having been widely employed for this purpose. CADD, specifically the commonly used support vector machines (SVMs), can employ machine learni...

Artificial intelligence in drug development: present status and future prospects.

Drug discovery today
Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power coupled with advancements in AI technology could ...

Artificial intelligence for aging and longevity research: Recent advances and perspectives.

Ageing research reviews
The applications of modern artificial intelligence (AI) algorithms within the field of aging research offer tremendous opportunities. Aging is an almost universal unifying feature possessed by all living organisms, tissues, and cells. Modern deep lea...

An overview of neural networks for drug discovery and the inputs used.

Expert opinion on drug discovery
: Artificial intelligence systems based on neural networks (NNs) find rules for drug discovery according to training molecules, but first, the molecules need to be represented in certain ways. Molecular descriptors and fingerprints have been used as ...

Machine Learning Distinguishes with High Accuracy between Pan-Assay Interference Compounds That Are Promiscuous or Represent Dark Chemical Matter.

Journal of medicinal chemistry
Assay interference compounds give rise to false-positives and cause substantial problems in medicinal chemistry. Nearly 500 compound classes have been designated as pan-assay interference compounds (PAINS), which typically occur as substructures in o...

Deep Confidence: A Computationally Efficient Framework for Calculating Reliable Prediction Errors for Deep Neural Networks.

Journal of chemical information and modeling
Deep learning architectures have proved versatile in a number of drug discovery applications, including the modeling of in vitro compound activity. While controlling for prediction confidence is essential to increase the trust, interpretability, and ...